**ROLE SUMMARY** As Pfizer expands its commitment to patients with gastroenterological disorders, in October of 2023 the company launched Etrasimod, a medicine to treat adults with moderate to severe ulcerative colitis. Pfizer US Medical affairs has an open position for a Medical Director to support this asset and address the care gaps of UC patients. […]